Home > Qtrly Results > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Mar2024]

GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Revenues ₹3,063 Cr ₹2,507 Cr ₹3,207 Cr ₹3,402 Cr ₹3,001 Cr ₹3,100 Cr ₹3,018 Cr ₹2,777 Cr
Expenses ₹2,559 Cr ₹2,715 Cr ₹2,745 Cr ₹2,770 Cr ₹2,603 Cr ₹2,626 Cr ₹2,539 Cr ₹2,346 Cr
Operating Income ₹504 Cr ₹-209 Cr ₹462 Cr ₹631 Cr ₹398 Cr ₹474 Cr ₹479 Cr ₹432 Cr
Other Income ₹773 Cr ₹45 Cr ₹2 Cr ₹21 Cr ₹-42 Cr ₹71 Cr ₹86 Cr ₹183 Cr
Interest ₹149 Cr ₹134 Cr ₹121 Cr ₹112 Cr ₹109 Cr ₹97 Cr ₹83 Cr ₹60 Cr
Depreciation ₹151 Cr ₹147 Cr ₹141 Cr ₹155 Cr ₹135 Cr ₹152 Cr ₹146 Cr ₹147 Cr
Profit Before Tax ₹531 Cr ₹-521 Cr ₹-124 Cr ₹333 Cr ₹-688 Cr ₹330 Cr ₹337 Cr ₹408 Cr
Profit After Tax ₹-1,239 Cr ₹-450 Cr ₹-180 Cr ₹173 Cr ₹-549 Cr ₹186 Cr ₹172 Cr ₹211 Cr
EPS ₹-43.17 ₹-12.45 ₹-2.90 ₹5.31 ₹-15.18 ₹9.66 ₹9.23 ₹6.82
Industry Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS -0.6% -3.4% 69.9%
SUN PHARMACEUTICAL INDUSTRIES -2.9% 0% 59.6%
CIPLA 5.8% 6.2% 60.9%
DR REDDYS LABORATORIES 0.9% -1.5% 32.2%
ZYDUS LIFESCIENCES -2.6% 15.3% 114.4%
DIVIS LABORATORIES 5% 8% 25.9%
MANKIND PHARMA -2.3% -14% 57.7%
TORRENT PHARMACEUTICALS -3.4% -2.7% 61.2%
LUPIN -2.8% 2.1% 110.5%

GLENMARK PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

22.19 %

Y-o-Y

2.08 %

Quarters Revenues % Change
Mar2024 ₹3,063 Cr
22.19
Dec2023 ₹2,507 Cr
-21.85
Sep2023 ₹3,207 Cr
-5.71
Jun2023 ₹3,402 Cr
13.37
Mar2023 ₹3,001 Cr
-3.21
Dec2022 ₹3,100 Cr
2.73
Sep2022 ₹3,018 Cr
8.66
Jun2022 ₹2,777 Cr -

GLENMARK PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

Positive

Y-o-Y

26.75 %

Quarters Operating Profit % Change
Mar2024 ₹504 Cr
Positive
Dec2023 ₹-209 Cr
Negative
Sep2023 ₹462 Cr
-26.76
Jun2023 ₹631 Cr
58.63
Mar2023 ₹398 Cr
-16.06
Dec2022 ₹474 Cr
-1.03
Sep2022 ₹479 Cr
10.98
Jun2022 ₹432 Cr -
Operating Margins
Q-o-Q

Positive

Y-o-Y

24.21 %

Quarters Operating Margin% % Change
Mar2024 16.47%
Positive
Dec2023 -8.32%
Negative
Sep2023 14.41%
-22.36
Jun2023 18.56%
39.97
Mar2023 13.26%
-13.28
Dec2022 15.29%
-3.65
Sep2022 15.87%
2.12
Jun2022 15.54% -

GLENMARK PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Mar2024 ₹-1,239 Cr
Negative
Dec2023 ₹-450 Cr
Negative
Sep2023 ₹-180 Cr
Negative
Jun2023 ₹173 Cr
Positive
Mar2023 ₹-549 Cr
Negative
Dec2022 ₹186 Cr
8.14
Sep2022 ₹172 Cr
-18.62
Jun2022 ₹211 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Mar2024 -40.44 %
Negative
Dec2023 -17.94 %
Negative
Sep2023 -5.62 %
Negative
Jun2023 5.09 %
Positive
Mar2023 -18.31 %
Negative
Dec2022 5.99 %
5.27
Sep2022 5.69 %
-25.13
Jun2022 7.6 % -

GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Mar2024 ₹-43.17
Negative
Dec2023 ₹-12.45
Negative
Sep2023 ₹-2.9
Negative
Jun2023 ₹5.31
Positive
Mar2023 ₹-15.18
Negative
Dec2022 ₹9.66
4.66
Sep2022 ₹9.23
35.34
Jun2022 ₹6.82 -

You may also like the below Video Courses